Niacinamide

Niacinamide

SCHEMBL4472261

NC(=O)c1cccnc1.O=CC[C@H](O)[C@H](O)CO

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.59
F7 P08709 1/20 0.59
F3 P13726 1/20 0.59
SARM1 Q6SZW1 1/20 0.59
SIRT6 Q8N6T7 1/20 0.59
SIRT1 Q96EB6 1/20 0.59
SIRT3 Q9NTG7 1/20 0.59
SIRT5 Q9NXA8 1/20 0.59
SIRT4 Q9Y6E7 1/20 0.59
MKNK1 Q9BUB5 2/20 0.42
MKNK2 Q9HBH9 2/20 0.42
THRB P10828 1/20 0.42
ALDH1A1 P00352 2/20 0.41
APP P05067 1/20 0.41
GAA P10253 1/20 0.41
HCAR3 P49019 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
PLOD2 O00469 1/20 0.40
TBXAS1 P24557 1/20 0.40
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Niacinamide SCHEMBL28309509 1.00 SIRT2 (0.59) SIRT2F7F3SARM1SIRT6
Adonitol SCHEMBL27591282 0.84 F7 (0.69) SIRT2F7F3SARM1SIRT6
Mannitol SCHEMBL9807801 0.84 F7 (0.69) SIRT2F7F3SARM1SIRT6
Xylose SCHEMBL938610 0.83 F7 (0.58) SIRT2F7F3SARM1SIRT6
Xylose SCHEMBL23925306 0.83 F7 (0.58) SIRT2F7F3SARM1SIRT6
Xylose SCHEMBL28724079 0.82 F7 (0.56) SIRT2F7F3SARM1SIRT6
Demannose SCHEMBL27666893 0.82 F7 (0.56) SIRT2F7F3SARM1SIRT6
Xylose SCHEMBL20423632 0.82 F7 (0.56) SIRT2F7F3SARM1SIRT6
Niacinamide SCHEMBL27877775 0.81 F7 (0.73) SIRT2F7F3SARM1SIRT6
Niacinamide SCHEMBL810723 0.80 F7 (0.58) SIRT2F7F3SARM1SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504489-B2 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2009-03-17 US disclosed
US-7056894-B2 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2006-06-06 US disclosed
US-20060084616-A1 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. 2006-04-20 US disclosed
EP-1370139-A2 INHIBITORS OF ADP-RIBOSYL TRANSFERASES, CYCLASES, AND HYDROLASES, AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2003-12-17 EP disclosed
US-20020132783-A1 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. 2002-09-19 US disclosed
WO-2002059084-A2 INHIBITORS OF ADP-RIBOSYL TRANSFERASES, CYCLASES, AND HYDROLASES, AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2002-08-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020132783-A1 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof CD38, ADPRS, NTPCR SIRT2 731/4885F7 4070/4885F3 1181/4885
US-20060084616-A1 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof CD38, ADPRS, NTPCR SIRT2 692/4885F7 4201/4885F3 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.